ZSTK3341
ZSTK3341 is an aryl hydrocarbon receptor (AhR) and cytochrome P450 1A1 (CYP1A1) dependent cell growth inhibitor. ZSTK3341 exhibits growth inhibitory activity against cancer cells. ZSTK3341 can be used in the research of triple-negative breast cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C20H14FN5
- Molecular Weight:343.36
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
CYP1A1 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-468 | IC50 |
2.89 nM
|
Antiproliferative activity against parental MDA-MB-468 (MM468) triple-negative breast cancer cells assessed as reduction in cell viability incubated for 72 hrs by Cell Counting Kit-8 assay.
Antiproliferative activity against parental MDA-MB-468 (MM468) triple-negative breast cancer cells assessed as reduction in cell viability incubated for 72 hrs by Cell Counting Kit-8 assay.
|
41628058 |
In Vitro
ZSTK3341 (0-10000 nM; 72 h) potently inhibits the growth of parental MDA-MB-468, Doxorubicin (HY-15142A)-resistant MDA-MB-468/AR, and Paclitaxel (HY-B0015)-resistant MDA-MB-468/PR cells, with IC50 values of 2.89, 9.18, and 3.81 nM, respectively[1].
ZSTK3341 (0.1-10000 nM; 72 h) inhibits the growth of wild-type and CYP1A1-knockout T47D breast cancer cells in a dose-dependent manner, but its activity is significantly reduced in AhR-knockout T47D breast cancer cells[1].
ZSTK3341 (0.6-10 nM) induces CYP1A1/CYP1B1 activity in wild-type T47D breast cancer cells, while this activity is significantly reduced in CYP1A1-knockout T47D breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB-468, MDA-MB-468/AR, MDA-MB-468/PR cells
-
Concentration:0.01, 0.1, 1, 10, 100, 1000, 10000 nM
-
Incubation Time:72 h
-
Result:Potently inhibited the growth of parental MM468 TNBC cells with an IC50 of 2.89 nM.
Inhibited the growth of Doxorubicin-resistant MM468/AR TNBC cells with an IC50 of 9.18 nM, maintaining efficacy comparable to its activity in parental cells.
Inhibited the growth of Paclitaxel-resistant MM468/PR TNBC cells with an IC50 of 3.81 nM, maintaining efficacy comparable to its activity in parental cells.
-
Cell Line:wild-type T47D breast cancer cells, AhR-knockout T47D breast cancer cells, CYP1A1-knockout T47D breast cancer cells
-
Concentration:0.01, 0.1, 1, 10, 100, 1000, 10000 nM
-
Incubation Time:72 h
-
Result:Inhibited the growth of wild-type and CYP1A1-knockout T47D cells in a dose-dependent manner.
Showed significantly reduced growth inhibition activity in AhR-knockout T47D cells across all tested concentrations.
Chemical Information
-
Molecular Weight 343.36
-
Formel C20H14FN5
-
SMILES
FC(C=C1)=CC=C1C2=NC(N3C(C=CC=C4)=C4N=C3)=NC5=C2C=CN5C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Protocol for Cell Counting and Cell Density Analysis
Cell counting and cell-density analysis estimate the number of cells in a known volume or field area. Manual hemocytometer counting uses a chamber of defined geometry to convert counted cells into cells/mL, while automated counters and image-analysis workflows detect cell objects from optical, brightfield, fluorescence, impedance, or digital-image features. Trypan blue viability counting is based on dye exclusion: viable cells with intact membranes exclude dye, while non-viable cells with compromised membranes stain blue. The readout is total cell density, viable-cell density, dead-cell density, and percent viability. Cell density can also be estimated from microscopy images by counting objects per image area, from flow cytometry using calibrated volume or reference particles, or from in situ microscopy in bioreactors after calibration against reference methods such as hemocytometer or flow cytometry.
-
Somatic Cell Culture
A method of simulating the in vivo environment in vitro to maintain the cell growth, differentation and main functions.
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Cell Counting-Based Growth Curve Assay
Cell counting-based growth curve assays quantify cell proliferation by directly measuring changes in viable cell number over time using manual or automated counting methods such as hemocytometer-based counting or instrument-assisted cell enumeration, enabling construction of growth curves that reflect population expansion dynamics in response to culture conditions. A widely used approach is trypan blue exclusion with hemocytometer counting, where membrane-compromised (non-viable) cells take up the dye, allowing discrimination between viable and non-viable cells while simultaneously enabling total cell number quantification. Repeated sampling across time points allows estimation of proliferation rate, growth phases, and comparative growth kinetics between experimental conditions.
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- ZSTK3341
- ZSTK 3341
- ZSTK-3341
- Aryl Hydrocarbon Receptor
- Cytochrome P450
- aryl hydrocarbon receptor
- AhR-knockout cells
- MDA-MB-468 TNBC cells
- CYP1B1
- pan-caspase inhibitor
- triple-negative breast cancer cells
- T47D breast cancer cells
- cytochrome P450 1A1
- paclitaxel-resistant MDA-MB-468/PR TNBC cells
- adriamycin-resistant MDA-MB-468/AR TNBC cells
- Inhibitor
- inhibitor
- inhibit